| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DHRS2 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | EXOC6B | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | GATM | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | BIN2 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | OR1J2 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | ERRFI1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | EBF3 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | CDT1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | THAP1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | PURA | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
